Push to reduce wait times
KUALA LUMPUR: Nearly 15,000 patients are currently on the waiting list for various elective surgeries at government hospitals, says the Health Ministry.
Its minister Datuk Seri Dr Dzulkefly Ahmad ( pic ) said the ministry acknowledged the prolonged waiting periods.
He assured that emergency operations are carried out promptly without compromising patient safety.
'A total of 9,233 patients are currently waiting for cataract surgeries at 56 hospitals nationwide, with an average waiting period of three months.
'Meanwhile, 2,661 patients await procedures related to kidney stones, such as percutaneous nephrolithotomy and retrograde intrarenal surgery, with an average waiting period of 11 months available at 13 hospitals with resident urology surgical specialists,' he said.
He was responding to a question by Yeo Bee Yin (PH-Puchong), who had asked for the number of patients on the waiting list and the average waiting period.
Dzulkefly said 2,293 patients are in line for major cardiothoracic surgeries, including coronary artery bypass graft and heart valve surgeries, which have a waiting period of seven months.
'The paediatric cardiothoracic surgeries face an even longer delay, with 603 elective cases pending and an average waiting time of 21 months,' he added.
To address these lengthy waiting periods, the Health Ministry has implemented several initiatives, Dzulkefly revealed.
'These include expanding the cluster hospital concept and deploying surgical specialists to more hospitals lacking resident experts to initiate services.
'Furthermore, collaborations between agencies and public-private partnerships are being pursued to reduce surgical waiting times,' he said while highlighting the establishment of the MAIWP-Hospital Selayang Cataract Surgery Centre, a collaboration between the ministry and Federal Territory Islamic Religious Council.
He also said the Health Services Outsourcing Programme is part of this effort to enhance access and expedite surgical treatment for patients in need.
'Such measures are expected to improve access and expedite surgical treatment for patients who require it,' he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
2 hours ago
- Free Malaysia Today
New 6% service tax won't hurt medical tourism, says health minister
Malaysia recorded RM2.72 billion in revenue from medical tourism last year, marking a 21% increase from 2023. (Bernama pic) PETALING JAYA : Malaysia's medical tourism is unlikely to be impacted by the expansion of the sales and service tax from July 1, according to the health ministry. Its minister Dzulkefly Ahmad said in a written parliamentary reply that the country's medical tourism sector is expected to remain competitively priced in the region, despite the 6% service tax imposed on foreign patients. 'This is because medical costs in Malaysia are still 30% to 40% lower than in neighbouring countries such as Indonesia, Thailand, and Singapore for key treatments including gastroenterology, cardiology, orthopaedics, and oncology,' he said. He was responding to Dr Ahmad Yunus Hairi (PN-Kuala Langat) who asked about the implications of the expanded SST on Malaysia's reputation as the leading medical tourism destination. Yunus pointed out that Malaysia had generated over RM2 billion in revenue and attracted 1.3 million medical tourists from around the world in 2023. In June, the finance ministry announced a 6% service tax on private healthcare, traditional and complementary medicine, and allied health services provided to foreigners. The tax applies to service providers whose total taxable revenue from all services exceeds RM1.5 million over the past 12 months. Dzulkefly said the medical tourism industry continues to show highly positive growth. 'In 2024, the sector's performance has seen even stronger growth, with revenue from health tourism rising to RM2.72 billion, a 21% increase from the previous year. This was driven in part by a 14% increase in arrivals, with 1.59 million health tourists recorded,' he said. He added that Malaysia's health tourism sector offers not only competitive pricing, but is also recognised for its quality of care, clinical effectiveness, and signature Malaysian hospitality.
New Straits Times
3 hours ago
- New Straits Times
Malaysia remains top medical tourism hub despite SST, says minister
KUALA LUMPUR: Malaysia is expected to maintain its position as a leading medical tourism hub in the region and remain competitively priced, despite the recent imposition of a six per cent Sales and Service Tax (SST) on medical tourists. Health Minister Datuk Seri Dr Dzulkefly Ahmad said this was because Malaysia's medical costs are at least 30 to 40 per cent lower compared to neighbouring countries such as Indonesia, Thailand, and Singapore across several major treatment categories. These include gastroenterology, cardiology, orthopaedics, and oncology. "At the same time, the country's medical tourism sector not only offers competitive pricing but is also recognised for its high-quality services and effective treatments. "It also highlights Malaysian hospitality, which remains a major draw for medical tourists," he said in a written parliamentary reply. Dzulkefly said Malaysia's medical tourism revenue rose to RM2.72 billion last year, a 21 per cent increase compared to 2023. He was responding to Datuk Dr Ahmad Yunus Hairi (PN–Kuala Langat), who asked about the implications of the SST expansion on Malaysia's reputation as the region's top medical tourism destination.
New Straits Times
3 hours ago
- New Straits Times
NST Leader: Seeking a cure for rising medical costs
Here's a situation no one wants to face — medically or financially. A senior citizen went to a private hospital's emergency unit for a suspected heart attack and was quickly stabilised by the medical staff. Doctors recommended admission to the Intensive Care Unit for two weeks at an astronomical cost of RM250,000. Stunned by the prospect of financial ruin, the patient responded: "If the heart attack doesn't kill me, the hospital bill will." The senior citizen opted to be transferred to a government hospital. The bill for two weeks of treatment came to RM4,000, with another RM36,000 for three angioplasties. The difference in cost highlights the stark choices an uninsured Malaysian must make to receive treatment. This is why the Health Ministry is pushing for Reset, an initiative to address medical inflation by amending the Private Healthcare Facilities and Services Act 1998 to allow for the Diagnosis-Related Group (DRG) payment system. The system will stabilise long-term insurance premiums and improve price transparency. Rising private healthcare costs are often dismissed as a "problem for the rich". They are not. Rising medical costs affect a massive portion of Malaysians, regardless of income level. Medical inflation soared by 15 per cent in 2022, surpassing the regional average of 11 per cent, driven by rising medical technology costs and demographic pressures. The government, to its credit, has not capitulated to private healthcare providers and insurers' assertions that tighter pricing regulations reduce quality and discourage innovation. Instead, it is working on regulatory measures in healthcare financing and private health insurance that balance affordability, sustainability, and quality — while addressing the concerns of private providers and insurers. Instead, it is working on regulatory measures in healthcare financing and private health insurance that balance affordability, sustainability and quality, while addressing the concerns of private providers and insurers. The ministry is reviewing private hospital regulations to curb high, unregulated hospital supply costs, a major driver of claim expenses. Bank Negara has ordered insurers to stagger premium increases to reduce the financial impact on policyholders. To be fair, medical costs are increasing because of rising cost of imported technologies and drugs, increased wages for healthcare professionals, overuse of medical services and the overprescribing of medicines. The poor lifestyles choices of Malaysians don't help, either.
